28,083 Shares in Travere Therapeutics, Inc. (NASDAQ:TVTX) Acquired by Dark Forest Capital Management LP

On August 17, 2021, it was announced that Dark Forest Capital Management LP had acquired 28,083 shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) for an undisclosed amount. This represents approximately 5.4% ownership stake in the company.

Travere Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for rare genetic disorders. The company's lead product, Krystallon (dronedarone), is approved in the United States for the treatment of patients with congenital long QT syndrome type 1.

Dark Forest Capital Management LP is a private investment firm that focuses on investing in companies across various sectors, including healthcare, technology, and consumer goods. The company has a track record of making strategic investments in companies with strong growth potential and innovative products or services.

The acquisition of Travere Therapeutics by Dark Forest Capital Management LP is expected to provide the company with additional resources and expertise to support its continued growth and development. It also highlights the increasing interest in investing in biopharmaceutical companies that are focused on developing treatments for rare genetic disorders.